News

Stanford scientists 'totally surprised' by potential Parkinson's treatment discovery
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Parkinson’s disease: Common cough syrup revealed to slow down cognitive decline and dementia
A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...
Psychology Today23h
5 Reasons People Don’t Disclose Their Parkinson’s
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
Parkinson's: Cough medicine may help slow down cognitive decline
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
Texan explores young-onset Parkinson’s in Audible comedy series ‘Shaky’
For Oak Cliff native Katherine Craft, the new audio comedy series Shaky is personal. The writer-director’s nine-episode ...
How A Cheap, 3D-Printed Pen May Be Able To Help Diagnose Parkinson's Early
Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...
Explore more
Kirk Gibson foundation's CEO prepares to climb Mount Kilimanjaro with 1 leg
Former Tigers outfielder Kirk "Gibby" Gibson created the Parkinson's foundation after he was diagnosed with the disease in ...
European Medical Journal1d
Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?
Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.